Bergman, Martin J. http://orcid.org/0000-0002-8948-5264
Zueger, Patrick
Patel, Jayeshkumar http://orcid.org/0000-0001-7507-8054
Saffore, Christopher D.
Topuria, Ia
Cavanaugh, Cristi
Fang, Siran
Clewell, Jerry
Ogdie, Alexis
Funding for this research was provided by:
AbbVie
Article History
Received: 22 September 2022
Accepted: 13 October 2022
First Online: 4 November 2022
Funding
: This work/study, and Rapid Service Fee, was funded by AbbVie Inc. AbbVie participated in the study design, research, data collection, analysis and interpretation of data, writing, reviewing, and approving the publication. All authors had access to the data results, and participated in the development, review, and approval of this abstract. No honoraria or payments were made for authorship.
: Medical writing services provided by Samantha D. Francis Stuart, PhD, of Fishawack Facilitate Ltd, part of Fishawack Health, and funded by AbbVie.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: J Patel, P Zueger, and CD Saffore substantially contributed to study conception and design; I Topuria, C Cavanaugh, J Patel, P Zueger, and CD Saffore contributed to data acquisition; S Fang contributed to data analysis. All authors contributed to interpretation of results and in drafting/revising critically for intellectual content.
: The authors confirm that these data have not been previously presented or publicly shared.
: MJ Bergman has received speaking/consulting fees from AbbVie, Amgen, BMS, GSK, Janssen, Merck, Novartis, Pfizer, Sandoz, Sanofi, and Scifer; and is a shareholder of Merck and Johnson & Johnson. P Zueger, J Patel, CD Saffore, S Fang, and J Clewell are employees of AbbVie and may own stock. I Topuria and C Cavanaugh are employees of OM1, Inc. and may own stock. A Ogdie has received consulting fees from Amgen, AbbVie, BMS, Celgene, CorEvitas (previously Corrona, LLC), Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB, and has received grant support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatology Research Foundation, National Psoriasis Foundation, AbbVie, Amgen, Pfizer, and Novartis.
: This study was conducted in accordance with the ethical principles that have their origin in the current Declaration of Helsinki and was consistent with International Conference on Harmonisation Good Clinical Practice, Good Epidemiology Practices, and applicable regulatory requirements. This study utilized de-identified data from an administrative claims database, thus no ethics committee approval was required.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.